Business
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Chemours
New York, New York--(Newsfile Corp. - May 9, 2024) - Faruqi & Faruqi, LLP, a leading national...
About this update from Core Silver Corp.
[{"type":"text","content":"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ChemoursNew York, New York--(Newsfile Corp. - May 9, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company (\"Chemours\" or the \"Company\") (NYSE: CC) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Chemours To Contact Him Directly To Discuss Their OptionsIf you suffered losses exceeding $100,000 investing in Chemours stock or options between February 10, 2023 and February 28, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CC.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) certain of Chemours' senior executive officers manipulated Free Cash Flow targets as a means to maximize additional cash and stock incentive compensation applicable to executive officers pursuant to Chemours' Annual Incentive Plans and Long-Term Incentive Plans; and (ii) Chemours' accounting practices and procedures, including its internal control over financial reporting, were deficient.The Chemours class action lawsuit further alleges that on February 13, 2024, Chemours \"announced that it has postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023.\" The complaint alleges that according to Chemours, the delay was necessary \"because it needs additional time to complete its year-end reporting process\" and \"is evaluating its internal control over financial reporting . . . with respect to maintaining effective cont...